We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ZBIO market cap is 291.28M. The company's latest EPS is USD -0.8883 and P/E is -7.87.
| Quarter End | Sep 2024 | |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Revenue | 0 | |
| Operating Income | -40.99M | |
| Net Income | -38.61M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Revenue | 0 | 50M |
| Operating Income | -76.2M | -37.15M |
| Net Income | -119.28M | -37.12M |
| Quarter End | Sep 2024 | |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Assets | 403.43M | |
| Total Liabilities | 44M | |
| Total Equity | 359.44M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Assets | 74.58M | 68.18M |
| Total Liabilities | 26.78M | 43.82M |
| Total Equity | -192.29M | -225.72M |
| Market Cap | 291.28M |
| Price to Earnings Ratio | -7.87 |
| Price to Sales Ratio | 5.84 |
| Price to Cash Ratio | 5.14 |
| Price to Book Ratio | 11.99 |
| Dividend Yield | - |
| Shares Outstanding | 41.79M |
| Average Volume (1 week) | 144.9k |
| Average Volume (1 Month) | 212.23k |
| 52 Week Change | -30.44% |
| 52 Week High | 26.11 |
| 52 Week Low | 5.83 |
| Spread (Intraday) | 1.8 (21.18%) |
| Company Name | Zenas BioPharma Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
